Monday, September 24, 2012

Trichomonas vaginalis


                           Trichomonas vaginalis
History:
¢ First observed by Donne in 1836 in vaginal secretions.
Habitat:
¢ Inhabit
-         Female: vagina and urethra
-         Male: prostate gland, seminal vesicles and   urethra.
Morphology
¢ Exist only as trophozoites and
     is infective form of parasite.
¢ Cyst form absent.
¢ Trophozoites:
-         Shape: ovoid or pear-shaped.
-         Size: 7-23µm in length and   6-8µm wide.
-         Short undulating membrane reaching upto the middle of the body.
-         Single nucleus, located in the anterior portion .
-         Prominent axostyle that runs throughout the length of  the body and projects posteriorly.
-         Presence of five flagella, impart charcteristic motility known as wobbling or rotatory movement.
-         Four anterior  free flagella, arising from a shallow depression in the anterior end of the body called periflagellar canal.
-         Fifth flagellum curves back along the margin of the undulating membrane and is called the recurrent flagellum.
-         Not enclosed by undulating membrane but lies in a shallow groove in the free margin of the membrane.
-         Just beneath the membrane lies the costa, a unique rigid cord, filamentous in appearance that supports undulating membrane.
-         Cytoplasm contains large numbers of chromatin granules around costa and axostyle.
-         Simple, completed in a single host either male or female.
-         Infection transmitted sexually from a women acting as a reservior of infection to man.
-         In female, parasite gets nourishment from the mucosal surface of the vagina, and from the ingested bacteria and erythrocytes.
-         Reproduce by longitudinal binary fission, begins by division of nucleus, followed by division of neuromotor apparatus and finally separation of cytoplasm into two daughter trophozoites.
-         Trophozoites are infective stages.
-         On sexual contact, trophozoites transmitted to male and localise in the urethra and prostate gland.
-         These trophozoites under go replication in the same way as in vagina of female.
Pathogenesis
¢ Non invasive parasite, remains adherent to the mucosal epithelium of the vagina or urethra and causes superficial lesions. Infects squamous epithelium but not columnar epithelium.
¢ Virulence factor:
-         Protein liquids and Proteases- helps in adherence of trophozoites to epithelial cells of the genito-urinary tract.
-         Enzyme cysteine protease- responsible for haemolytic activity.
-         Normally,vaginal epithelial surface is rich in glycogen and lactobacillus. Lactobacillus converts glycogen to lactic acid that maintains acidic pH of vagina.
-         Parasite feed on host vaginal cells, results in disruption of the glycogen levels and vaginal bacterial flora leading to rise in pH level. The parasite thrives at pH levels that exceed 4.9.
-         May occur epithelial erosion which lead to petechial haemorrhage and metaplastic changes in the epithelium.
Clinical disease
¢ Incubation period- ranges from 4-28 days.
¢ Cause trichomoniasis.
¢ In women,
-         altered vaginal environment is common, have a scant, watery vaginal discharge.
-          Vaginitis may occur, with symptoms like itching, burning and painful urination along with profuse, forthy and malodorous discharge containg bacteria, pus and trophozoites.
-         PID most important complication.
-         Pregnant women infected with T.vaginalis , more likely to have premature rupture of membranes, premature birth and pre-term or low birth weight baby.
¢ In men,
-         infections are usually asymptomatic.
-         Occasionally experience urethritis, prostatitis and cystitis.
-         May occur infertility.
¢ Both in male and female, infection is associated with gonorrhoea, chlamydia, and HIV infections.
Laboratory diagnosis
¢ Specimen: vaginal and urethral discharges, prostatic secretion, endocervical specimens or urine sediments.
¢ Microscopy:
-         Direct wet mount: a small amont of freshly collected specimen is mixed with a drop of saline on a microscope slide and covered with a coverslip. Examine under low power for presence of actively motile trophozoites. If motility diminishes, it may be possible to observe movement of undulating membrane, under high dry power.
-         Staining: stained (giemsa, papanicolaou) preparetion of dry smear may be examined, but oragnisms may be difficult to recognise.

¢ Culture:
-         More sensitive than wet mount (93% sensitivity), but not routinely used as it is expensive and somewhat technically difficult.
-         Variety of media like
Ø Bushley’s, Feinberg-Whittington, Roiron’s and Johnson-Trussel etc can be used.
Ø CPLM (Cysteine peptone liver maltose) medium is frequently employed.
Ø Plastic envelope medium is also used and its sensitivity is reported to be superior to other available techniques.
¢ Other methods:
a)     Serological test: indirect haemagglutination and gel diffusion test are used for antibody detection.
b)    Gene probes: monoclonal antibodies and DNA probes are also effective.
c)     PCR: also used nowadays. 
Treatment
¢ Metronidazole (200-250 mg orally thrice daily for 5-7 days)
¢ To prevent recurrence, patient’s sexual partner should be tested and trated.
¢ Strains resistant to metronidazole is treated with tinidazole.
¢ During pregnancy, topical therapy with clotrimazole, in a dose of 100mg daily for 6 days is effective.



Sunday, September 23, 2012

Laboratory contamination and infection


           Laboratory contamination and infection
      In laboratory
Ø Skin and eyes
Ø Mouth
Ø Respiratory tract
      Outside laboratory
Classification of microorganisms on the basis of hazard
      Risk group I
e.g: food spoilage bacteria,
       common molds and yeast
Presents low risk to laboratory workers and community
Unlikely to cause human disease
      Risk group II
e.g: Staphylococci, Streptococci, Vibrio,
 Adeno virus, Polio virus etc
Presents moderate risk to laboratory workers and limited risk to community.
Cause serious human disease but not serious hazard
Effective preventive measures and treatment available.
      Risk group III
e.g: brucella, tubercle bacilli, salmonella typhi., HIV etc
High risk to laboratory worker and low risk to community.
Do not ordinarily spread rapidly from one individual to another.
Effective vaccines and therapeutic material available. 
      Risk group IV
e.g: agents in this group are all viruses.
High risk to both.
Cause serious disease
Transmitted from one person to another
No vaccine and treatment available.
Classification of laboratories
      Basic
      Containment
      Maximum containment
Laboratory waste disinfection and decontamination
      Decontamination using chemical disinfectants
      By autoclave
      By incineration

Neuromuscular junction


                  Neuro muscular junction
Neuromuscular junction
junction between terminal branch of the nerve fiber and muscle fiber.
¨  The neuromuscular junction is the point of synaptic contact between axon terminal of the motor neuron and the muscle fiber it control
¨  Action potential in the motor neuron cause acetylcholine release into the NMJ
¨  Muscle contraction follows the delivery of Ach to the muscle fiber
¨  A single motor unit consists of a motor neuron and all of the muscles fibers it controls
¨  The smallest part of the muscle that can contract individually is known as motor unit
Structure of neuromuscular junction
Ø  Synaptic tough →axon terminal
Ø  Synaptic cleft →is the space between axon terminal and sarcolemma
Ø  Subneural cleft →fold present in muscle fiber
Ø  Synaptic vesicle →presence in axon terminal and its function is to store Ach
Neuromuscular transmission
¨  Defined as the transfer of information from motor nerve ending to the muscle fiber through NMJ
¨  Transmission takes place by following  steps:
                        1. release of Ach
                        2.action of Ach
                        3.development of Epp
                        4.destruction of Ach
1.Release of acetylcholine
¨  When AP reaches to axon terminal, it increases permeability of presynaptic membrane for ca++ by opening of voltage gated calcium channel which is +nce in membrane of axon terminal
¨  Calcium ion enters to axon terminal from ECF
¨  Excess of ca++ releases the acetylcholine from syanaptic vesicle through exocytosis as “quanta” or “packets”
¨  The Ach diffuses across through the presynaptic membrane & enter the synaptic cleft
2.Action of acetylcholine
¨  Ach binds with nicotinic receptor +nce in the post synaptic membrane
¨  It opens ligand gated channels for sodium
¨  Sodium ion enter from ECF but potassium cannot release out from muscle because potassium & ligand gated channel both have negative charge, so there is excess of sodium ion which produce an electrical potential called Endplate potential
3.End plate potential
¨  EPP is the change in the resting membrane potential when an impulse reaches the NMJ. The resting membrane potential at the NMJ is -90 mv. When sodium ions enters inside, slightly depolarization occurs up to -60 mv which is called EPP
¨  The EPP is not propagative. But it causes the development of APin the muscle fiber
4.Fate of acetylcholine
¨  Ach is released into the synaptic cleft is destroyed very quickly.
¨  With in 1 millisecond after the release into the synaptic cleft, it is destroyed by the acetylcholinesterase.
¨  However, the Ach line so potent, that even this short duration of 1 millisecond is sufficient to excite the muscle fiber
¨  Rapid destruction of Ach prevents the repeat excitation of the muscle fiber &allow the muscle to relax
Myasthenia gravis
¨  Antibodies to Ach receptor at NMJ
¨  This block ach receptors of NMJ
¨  Destroys Ach receptors & triggers endocytosis of Ach receptor.
¨  Neuromuscular transmission is blocked
¨  Easy fatigability on exercise
¨  May lead to paralysis
Lambert-Eaton syndrome
¨  Condition that resembles the myasthenia gravis
¨  Rare condition
¨  Antibodies to the voltage-gated calcium ion channels on nerves endings
¨  Impaired release of Ach at NMJ
¨  Proximal muscles of lower extremities are affected


Leukemia and its classification


Leukemia
         Definition:
            Leukemia is the malignant neoplasms of hemopoiectic stem cells characterized by diffuse replacement of bone marrow by neoplastic immature hemopoietic cells.
Classification
A)    Acute leukemias:
            Aute myeloblastic leukemia
            Acute lymphoblastic leukemia
B) Chronic leukemia:
            Chronic myeloid leukemia
            Chronic lymphocytic leukemia
                        -B cell leukemia
                        -T cell leukemia
           
Acute leukemias
a) Acute myeloblastic leukemia (FAB Classification):
                     M0-minimally differentiated acute       myeloblastic leukemia
                     M1-acute myeloblastic leukemia,         without maturation
                     M2-acute myeloblastic leukemia, with            granulocytic maturation
                     M3-acute promyelocytic leukemia
                     M4-acute myelomonocytic leukemia
                     M5-acute monocytic leukemia
                     M6-acute erythroid leukemias
                     M7-acute megakaryoblastic leukemia
b) Acute lymphoblastic leukemia: (FAB classification)
         ALL-L1: small uniform lymphoblasts
         ALL-L2: large varied lymphoblasts
         ALL-L3: large varied lymphoblas ts with vacuoles (bubble-like features)


             AML
    ALL
Auer rod
 Present
Absent
N:C ratio
High
high
Nucleoli
3-4
1-2
Chromatin
Less dense
dense
PAS stain
Negative
Positive
MPO
Positive
Negative
Sudan black B
Positive
Negative